JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37,623 | +70.0% | 20,337 | +2.0% | 0.00% | – |
| Q4 2022 | $22,125 | -52.9% | 19,932 | -0.4% | 0.00% | – |
| Q3 2022 | $47,000 | -21.7% | 20,004 | +1.4% | 0.00% | – |
| Q2 2022 | $60,000 | -45.9% | 19,722 | +20.5% | 0.00% | -100.0% |
| Q1 2022 | $111,000 | -24.0% | 16,367 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $146,000 | +9.0% | 17,519 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $134,000 | +6.3% | 18,043 | -2.3% | 0.00% | – |
| Q2 2021 | $126,000 | +22.3% | 18,472 | +83.7% | 0.00% | – |
| Q1 2021 | $103,000 | +47.1% | 10,057 | +0.3% | 0.00% | – |
| Q4 2020 | $70,000 | -16.7% | 10,030 | -2.8% | 0.00% | – |
| Q3 2020 | $84,000 | +15.1% | 10,318 | -2.2% | 0.00% | – |
| Q2 2020 | $73,000 | +62.2% | 10,553 | +10.2% | 0.00% | – |
| Q1 2020 | $45,000 | -48.9% | 9,578 | -5.5% | 0.00% | – |
| Q4 2019 | $88,000 | +158.8% | 10,132 | -0.8% | 0.00% | – |
| Q3 2019 | $34,000 | -33.3% | 10,216 | -0.7% | 0.00% | – |
| Q2 2019 | $51,000 | -17.7% | 10,288 | +2.3% | 0.00% | – |
| Q1 2019 | $62,000 | +77.1% | 10,054 | -3.1% | 0.00% | – |
| Q4 2018 | $35,000 | -48.5% | 10,380 | -0.8% | 0.00% | – |
| Q3 2018 | $68,000 | -13.9% | 10,460 | +1.8% | 0.00% | – |
| Q2 2018 | $79,000 | -61.8% | 10,271 | +11.0% | 0.00% | -100.0% |
| Q1 2018 | $207,000 | +66.9% | 9,253 | -5.1% | 0.00% | – |
| Q4 2017 | $124,000 | -16.8% | 9,752 | +2.0% | 0.00% | -100.0% |
| Q3 2017 | $149,000 | +156.9% | 9,559 | +132.2% | 0.00% | – |
| Q2 2017 | $58,000 | – | 4,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |